Lung Cancer News

The addition of nivolumab to neoadjuvant chemotherapy followed by adjuvant nivolumab extended EFS among patients with resectable non-small cell lung cancer, according to the agent’s manufacturer.

Two phase 3 trials evaluating a regimen containing pembrolizumab plus lenvatinib for treatment of metastatic non-small cell lung cancer failed to meet their primary endpoints, according to the manufacturers of each agent.

Approximately one-third (34.3%) of chatbot recommendations about cancer treatment do not appear in National Comprehensive Cancer Network guidelines, study results published in JAMA Oncology showed.

Relative risk for venous thromboembolism appeared high among patients with COVID-19 and cancer who received specific cancer treatments, according to study results published in JAMA Oncology.

Osimertinib plus chemotherapy conferred significantly greater improvement in PFS compared with osimertinib alone in patients with EGFR-mutated advanced non-small cell lung cancer, according to study results.

The addition of benmelstobart and anlotinib to chemotherapy significantly improved median PFS and OS compared with chemotherapy alone among patients with extensive-stage small cell lung cancer, according to study results.

Results from the American Association for Cancer Research’s annual Cancer Progress Report revealed that the age-adjusted overall cancer death rate in the U.S. fell by 33% between 1991 and 2020.

Prescription medications added onto tobacco longitudinal care did not improve long-term abstinence rates among current smokers eligible for lung cancer screening, according to results published in JAMA Network Open.

Non-English-speaking individuals experienced significant systems-level barriers when they called hospitals trying to obtain information about cancer care services, according to study results.

Amivantamab-vmjw — with or without the addition of lazertinib — improved PFS versus chemotherapy alone in patients with EGFR-mutated non-small cell lung cancer, according to the agent’s manufacturer.